Seres Therapeutics, Inc.

8-K Results of operations (earnings release) Aug 5, 2026 8-K Entered a material agreement; Terminated a material agreement Aug 4, 2026 8-K Director or officer change; Shareholder vote results Jul 8, 2026 8-K Regulation FD disclosure; Other events Jul 8, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 5, 2026 8-K Director or officer change Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Other events Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 12, 2026 8-K Director or officer change Mar 2, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 5, 2025 8-K Other events Oct 3, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2025 8-K Director or officer change Jul 22, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2025 8-K Amended charter or bylaws Apr 22, 2025 8-K Director or officer change; Shareholder vote results; Other events Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 13, 2025 8-K Director or officer change Feb 27, 2025 8-K Director or officer change Feb 6, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Results of operations (earnings release); Other events Jan 10, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release); Delisting notice or listing-rule failure; Regulation FD disclosure Nov 13, 2024 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Oct 1, 2024 8-K Shareholder vote results Sep 26, 2024 8-K Regulation FD disclosure; Other events Sep 12, 2024 8-K Regulation FD disclosure Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2024 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity Aug 6, 2024 8-K Regulation FD disclosure Aug 6, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024